End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7,70,000 KRW | -1.28% | -1.41% | +1.32% |
25/04 | Samsung Bioepis Granted Approval to Market Autoimmune Treatment in Europe | MT |
25/04 | Samsung Biologics Posts Higher Q1 Profit, Sales | MT |
Chart calendar Samsung Biologics Co.,Ltd.
Upcoming events on Samsung Biologics Co.,Ltd.
Past events on Samsung Biologics Co.,Ltd.
24/04/2024 12:15 pm | Q1 2024 Earnings Release |
24/01/2024 12:30 pm | Q4 2023 Earnings Release |
09/01/2024 | JPMorgan Healthcare Conference |
14/11/2023 | Biomanufacturing World Summit |
24/10/2023 12:21 pm | Q3 2023 Earnings Release |
24/10/2023 | CPHI Worldwide |
18/09/2023 | BioProcess International Conference |
26/07/2023 12:02 pm | Q2 2023 Earnings Release |
26/07/2023 | MRNA-Based Therapeutics Summit |
05/06/2023 | BIO International Convention |
31/05/2023 | DDF Summit |
15/05/2023 | PEGS Summit |
24/04/2023 12:21 pm | Q1 2023 Earnings Release |
24/04/2023 | Q1 2023 Earnings Call |
12/04/2023 | American Biomanufacturing Summit |
17/03/2023 | Annual General Meeting |
09/03/2023 | Q4 2022 Earnings Release |
08/02/2023 12:30 pm | FY 2022 Earnings Call |
09/01/2023 | J.P. Morgan Healthcare Conference |
16/08/2022 | Interim 2022 Earnings Release |
Annual results
Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|
Net sales Billions KRW | Released Forecast Spread | 1 165 1 026 13.58% | 1 568 1 548 1.32% | 3 001 2 787 7.69% | 3 695 3 678 0.45% | 4 263 |
EBITDA Billions KRW | Released Forecast Spread | 436 391 11.6% | 699 671 4.23% | 1 292 1 161 11.28% | 1 603 1 485 7.97% | 1 791 |
EBIT Billions KRW | Released Forecast Spread | 293 248 18.3% | 537 540 -0.55% | 984 892 10.28% | 1 114 1 079 3.24% | 1 256 |
Earnings before Tax (EBT) Billions KRW | Released Forecast Spread | 0,00 0,00 - | 561 581 -3.42% | 1 009 862 17.07% | 1 120 1 077 4.03% | 1 249 |
Net income Billions KRW | Released Forecast Spread | 0,00 0,00 - | 394 431 -8.63% | 798 612 30.47% | 858 818 4.83% | 976 |
EPS KRW | Released Forecast Spread | 0,00 0,00 - | 5 949 6 512 -8.65% | 11 432 8 793 30.01% | 12 051 11 503 4.76% | 13 708 |
Announcement Date | 26/01/21 | 24/01/22 | 27/01/23 | 24/01/24 | - |
Quarterly results
Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Billions KRW | Released Forecast Spread | 444 453 -1.99% | 511 463 10.49% | 651 473 37.79% | 873 779 12.14% | 966 795 21.45% | 721 757 -4.75% | 866 805 7.62% | 1 034 1 002 3.15% | 1 074 1 061 1.15% | 947 929 1.93% | 989 | 1 050 | 1 264 |
EBITDA Billions KRW | Released Forecast Spread | 171 181 -5.62% | 216 195 10.9% | 259 194 33.34% | 409 428 -4.44% | 405 361 12.29% | 292 295 -0.91% | 362 318 13.9% | 458 412 11.21% | 353 | 457 | 497 | 548 | |
EBIT Billions KRW | Released Forecast Spread | 129 152 -15.08% | 176 154 14.36% | 170 148 15.03% | 325 230 41.06% | 313 256 21.98% | 192 202 -4.97% | 253 226 12.27% | 319 290 9.96% | 350 313 11.69% | 221 223 -0.93% | 289 | 321 | 393 |
Earnings before Tax (EBT) Billions KRW | Released Forecast Spread | 109 136 -19.62% | 199 170 16.71% | 214 158 35.91% | 198 244 -18.73% | 398 257 54.75% | 197 184 7.17% | 251 220 14.49% | 316 305 3.72% | 356 317 12.31% | 240 220 9.06% | 253 | 299 | 411 |
Net income Billions KRW | Released Forecast Spread | 79,3 131 -39.36% | 147 120 22.69% | 152 110 38.47% | 129 180 -28.32% | 370 186 99.02% | 142 162 -12.29% | 185 176 5.08% | 240 232 3.52% | 291 257 13.19% | 179 174 2.9% | 226 | 251 | 329 |
EPS KRW | Released Forecast Spread | 1 815 1 959 -7.36% | 5 258 2 205 138.43% | 1 992 1 989 0.17% | 2 597 2 285 13.68% | 3 376 2 895 16.61% | 4 084 2 981 37.01% | 2 749 | 3 105 | 3 315 | 4 178 | |||
Announcement Date | 24/01/22 | 27/04/22 | 27/07/22 | 26/10/22 | 27/01/23 | 24/04/23 | 26/07/23 | 25/10/23 | 24/01/24 | 24/04/24 | - | - | - |
Past sector events for Samsung Biologics Co.,Ltd.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- A207940 Stock
- Calendar Samsung Biologics Co.,Ltd.